Hot Topics · Cross-industry
Tariffs
Electrical equipment and supply-chain tariff exposure; product-level callouts.
AI-generated · informational only · not investment advice · verify before relying.
01 · The lede
Intelligence brief
SeventhBiz Intelligence
Refreshed 3h agoTariffs have transitioned from a forward-looking risk disclosure into an active, quantified operating cost variable affecting gross margin, capex planning, and supply chain architecture across industrial, healthcare, and technology companies. The 2026 Q4 filing cycle shows two distinct cohorts: companies receiving one-time refunds of invalidated IEEPA tariffs (MTD $52M, TILE $15.6M, IRTC $3M, KE managing pass-through recovery) are treating these as transient P&L items explicitly excluded from forward guidance, while simultaneously facing new permanent Section 301 tariffs on Swiss/Chinese imports (MTD 12.5%) and Section 232 escalations (MBC kitchen cabinets rising from 25% to 50% January 1, 2027, softwood lumber at 10%).…
The full brief is part of the subscription
03 · Companies
Companies engaging with this topic
Tracked companies with an on-record signal on Tariffs this cycle.
06 · Evidence
Recent mentions
Preview“the risks associated with tariffs and the uncertain duration of trade conflicts”
Safe Harbor Statement
“Significant tariffs or other restrictions, if imposed on our imported pharmaceutical ingredients, medical devices, medical equipment and their ingredients and components, could escalate costs of medications, medical devices and medical equipment and disrupt our supply chains.”
MD&A — Results of Operations — Clinical Staffing, Inflation, Future Medicaid Reductions and Tariffs
“impacts on the global economy, supply chain and fuel prices, generally, including as a result of changes to government trade policies”
Slide 2 — Cautionary Statement
Unlock Tariffs
The full intelligence brief, how the language shifted quarter over quarter, the bear case, and every company mention — verbatim and source-cited.